Sagentia was asked by Trinity Biotech to conduct the technical due diligence on Fiomi Diagnostics’ cardiac point-of-care diagnostic system prior to its potential acquisition.
http://www.sagentia.com/new-technologies
Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...
Case Study - Enabling the Trinity Biotech acquisition of Fiomi Diagnostics
1. The approach
Sagentia was asked by Trinity Biotech to conduct the
technical due diligence on Fiomi Diagnostics’ cardiac point-
of-care diagnostic system prior to its potential acquisition.
We evaluated the instrument, consumable and
manufacturing processes to comment on robustness;
suitability for high volume manufacture; and to identify
potential technical hurdles associated with the development
of an acceptable product..
The end result
Trinity Biotech was better informed about Fiomi Diagnostics
and able to make the acquisition for $13.1m with a solid
understanding of the company’s
current and future
technical position.
Technical due diligence
enables acquisition and
provides access to
$900m market